Cargando…
Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of γ-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
BACKGROUND: There has been accumulating evidence that there are associations among γ-glutamyltransferase (γ-GT) elevation and all-cause mortality, cardiovascular diseases and metabolic diseases, including nonalcoholic fatty liver disease. The primary objective of this study was to evaluate the impac...
Autores principales: | Ogusu, Naoki, Saruwatari, Junji, Nakashima, Hiroo, Noai, Madoka, Nishimura, Miki, Deguchi, Mariko, Oniki, Kentaro, Yasui-Furukori, Norio, Kaneko, Sunao, Ishitsu, Takateru, Nakagaswa, Kazuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220988/ https://www.ncbi.nlm.nih.gov/pubmed/25372290 http://dx.doi.org/10.1371/journal.pone.0111066 |
Ejemplares similares
-
Possible association between moderate intellectual disability and weight gain in valproic acid–treated patients with epilepsy
por: Tanamachi, Yukiko, et al.
Publicado: (2015) -
Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
por: Nakashima, Hiroo, et al.
Publicado: (2015) -
Expression of Concern: Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of γ-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
Publicado: (2023) -
Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy
por: Saruwatari, Junji, et al.
Publicado: (2010) -
Meta-Analyses of Manganese Superoxide Dismutase Activity, Gene Ala-9Val Polymorphism, and the Risk of Schizophrenia
por: Wang, Dong-Fang, et al.
Publicado: (2015)